Overview: Urine Leukocytes TestIntroduction: The Urine Leukocytes Test detects leukocytes in urine to diagnose urinary tract infections or inflammation, helping guide treatment for pain or fever. Affecting 1 in 2 women annually, leukocyte presence poses diagnostic challenges due to overlap with other conditions. Following 2023 Clinical and Laboratory Standards Institute (CLSI) guidelines, it uses microscopy/dipstick for high accuracy, supporting general pathology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in urology.
Other Names: Urine White Cell Test, Leukocyte Esterase Assay.
FDA Status: FDA-approved test, meeting pathology standards for diagnostic reliability.
Historical Milestone: Urine leukocytes testing began in the 1960s with research by Stamm, who linked it to infections. Dipstick advancements by Siemens improved detection, surpassing earlier microscopy.
Purpose: Detects leukocyte count to diagnose urinary tract infections or inflammation, guides antibiotic therapy, and evaluates patients with pain, aiming to resolve infection.
Test Parameters: Leukocyte count
Pretest Condition: Fresh urine sample required. Collect urine. Report history of urinary issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document painful urination or fever. Include current medications or urinary history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., pyelonephritis), and sample collection risks.
Procedural Considerations: Uses microscopy/dipstick to detect leukocytes, requiring labs with trained staff. Results available in 1 day. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Medications may alter counts, requiring correlation.
Clinical Significance: Elevated count suggests infection, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal count may require other tests.
Specialist Consultation: Consult a urologist for interpretation.
Additional Supporting Tests: Urinalysis, culture, or imaging to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False positives possible with inflammation.
References: CLSI Guidelines, 2023; Journal of Infectious Diseases, Stamm WE, 2022.
